Fabrizio Cantini

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 7

Top Topics

Radical Prostatectomy

Peritoneal Dialysis

Pulmonary Tuberculosis

Top Venues

Annals of the rheumatic diseases

Therapeutics and clinical risk management

Expert review of clinical immunology

Expert opinion on drug safety

This page only lists publications with an associated author ORCID identifier.

Publications

Sara Monti, Alessandra Milanesi, Catherine Klersy, Alessandro Tomelleri, Lorenzo Dagna, Campochiaro Corrado, Nicola Farina, Francesco Muratore, Elena Galli, Chiara Marvisi, Milena Bond, Alvise Berti, Roberto Bortolotti, Roberto Padoan, Franco Schiavon, Mara Felicetti, Carlotta Nannini, Fabrizio Cantini, Alessandro Giollo, Maurizio Rossini, Edoardo Conticini, Bruno Frediani, Fabrizio Conti, Roberta Priori, Marco Sebastiani, Giulia Cassone, Luca Quartuccio, Elena Treppo, Silvano Bettio, Ariela Hoxha, Marco Lovisotto, Giacomo Emmi, Irene Mattioli, Pietro Leccese, Roberto Caporali, Lorenza Maria Argolini, Rosario Foti, Elisa Visalli, Michele Colaci, Carlo Salvarani, Carlomaurizio Montecucco, null null
Age at diagnosis influences the clinical phenotype, treatment strategies and outcomes in patients with giant cell arteritis: results from the observational GCAGE study on a large cohort of 1004 patients. Annals of the rheumatic diseases (2023)
Maurizio Benucci, Arianna Damiani, Francesca Li Gobbi, Valentina Grossi, Maria Infantino, Mariangela Manfredi, Laura Niccoli, Fabrizio Cantini
Therapeutic Potential of Ixekizumab in the Treatment of Ankylosing Spondylitis: A Review on the Emerging Clinical Data. Therapeutics and clinical risk management 16 (2020)
Fabrizio Cantini, Corrado Blandizzi, Laura Niccoli, Linda Petrone, Delia Goletti
Systematic review on tuberculosis risk in patients with rheumatoid arthritis receiving inhibitors of Janus Kinases. Expert opinion on drug safety 19 (7) (2020)
Fabrizio Cantini, Delia Goletti, Linda Petrone, Saied Najafi Fard, Laura Niccoli, Rosario Foti
Immune Therapy, or Antiviral Therapy, or Both for COVID-19: A Systematic Review. Drugs 80 (18) (2020)
Fabrizio Cantini, Maurizio Benucci, Francesca Li Gobbi, Giulia Franchi, Laura Niccoli
Biosimilars for the treatment of psoriatic arthritis. Expert review of clinical immunology 15 (11) (2019)
Carlotta Nannini, Laura Niccoli, Stelvio Sestini, Iashar Laghai, Angela Coppola, Fabrizio Cantini
Remission maintenance after tocilizumab dose-tapering and interruption in patients with giant cell arteritis: an open-label, 18-month, prospective, pilot study. Annals of the rheumatic diseases 78 (10) (2019)
Fabrizio Cantini, Carlotta Nannini, Laura Niccoli, Linda Petrone, Giuseppe Ippolito, Delia Goletti
Risk of Tuberculosis Reactivation in Patients with Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Receiving Non-Anti-TNF-Targeted Biologics. Mediators of inflammation 2017 (2017)